Astragalus Polysaccharide Promotes Doxorubicin-Induced Apoptosis by Reducing O-GlcNAcylation in Hepatocellular Carcinoma
Cells · 10.03.2023 · 12 (6) · 866
DOI: 10.3390/cells12060866 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 10.03.2023. Verfasst von Mingzhe Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Budgeted projects in Shanghai University of TCM, National Natural Science Foundation of China.
Abstract (Originalsprache)
The toxicity and side effects of chemotherapeutic drugs remain a crucial obstacle to the clinical treatment of hepatocellular carcinoma (HCC). Identifying combination therapy from Chinese herbs to enhance the sensitivity of tumors to chemotherapeutic drugs is of particular interest. Astragalus polysaccharide (APS), one of the natural active components in Astragalus membranaceus, has been reported to exhibit anti-tumor properties in diverse cancer cell lines. The aim of this study was to determine the effect of APS on Doxorubicin (Dox)-induced apoptosis in HCC and the underlying mechanism. The results showed that APS dose-dependently promoted Dox-induced apoptosis and enhanced endoplasmic reticulum (ER) stress. Additionally, APS decreased the mRNA level and protein stability of O-GlcNAc transferase (OGT), and increased the O-GlcNAcase (OGA) expression. Furthermore, OGT lentiviral transfection or PugNAc (OGA inhibitor) treatment reversed the ER stress and apoptosis induced by the combination of Dox and APS. A xenograft tumor mouse model confirmed that the combination of APS and Dox showed an advantage in inhibiting tumor growth in vivo. These findings suggested that APS promoted Dox-induced apoptosis in HCC cells through reducing the O-GlcNAcylation, which led to the exacerbation of ER stress and activation of apoptotic pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Medical Sciences, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
- Department of Pharmacology, School of Medicine, Sun Yat-sen University, Shenzhen 518107, China.
ORCID-Profile: Fangfang Duan
Förderung
- Budgeted projects in Shanghai University of TCM
- National Natural Science Foundation of China
Zitieren
APA
Li, M., Duan, F., Pan, Z., Liu, X., Lu, W., Liang, C., Fang, Z., Peng, P., & Jia, D. (2023). Astragalus Polysaccharide Promotes Doxorubicin-Induced Apoptosis by Reducing O-GlcNAcylation in Hepatocellular Carcinoma. Cells, 12(6), 866. https://doi.org/10.3390/cells12060866
Vancouver
Li M, Duan F, Pan Z, Liu X, Lu W, Liang C, et al. Astragalus Polysaccharide Promotes Doxorubicin-Induced Apoptosis by Reducing O-GlcNAcylation in Hepatocellular Carcinoma. Cells. 2023;12(6):866. doi:10.3390/cells12060866
BibTeX
@article{Li2023,
author = {Li, Mingzhe and Duan, Fangfang and Pan, Zhiqiang and Liu, Xiaomei and Lu, Wenli and Liang, Chao and Fang, Zhaoqin and Peng, Peike and Jia, Dongwei},
title = {Astragalus Polysaccharide Promotes Doxorubicin-Induced Apoptosis by Reducing O-GlcNAcylation in Hepatocellular Carcinoma},
journal = {Cells},
year = {2023},
volume = {12},
number = {6},
pages = {866},
doi = {10.3390/cells12060866}
}
EUVIMED